The pathogenicity of GBA mutations in PD is thought to be related to reduced GCase activity (i.e. loss-of-function) as severe GBA mutations appear to be correlated with a higher risk of PD development and significantly worse motor and non-motor symptoms compared with mild mutations [58, 59]. This evidence concerns the gene GBA1 and Parkinson disease.